Do hospital microbiology laboratories still need to distinguish Candida albicans from Candida dubliniensis?
作者信息
Lockhart Shawn R
出版信息
J Clin Microbiol. 2011 Dec;49(12):4415. doi: 10.1128/JCM.05923-11. Epub 2011 Oct 12.
Abstract
摘要
相似文献
1
Do hospital microbiology laboratories still need to distinguish Candida albicans from Candida dubliniensis?医院微生物实验室仍需要区分白念珠菌和都柏林念珠菌吗？
J Clin Microbiol. 2011 Dec;49(12):4415. doi: 10.1128/JCM.05923-11. Epub 2011 Oct 12.
2
Can Multidrug-Resistant Candida auris Be Reliably Identified in Clinical Microbiology Laboratories?多重耐药性耳念珠菌在临床微生物实验室中能否得到可靠鉴定？
J Clin Microbiol. 2017 Feb;55(2):638-640. doi: 10.1128/JCM.02202-16. Epub 2016 Nov 23.
3
Rapid Identification of Candida Species from Positive Blood Cultures by Use of the FilmArray Blood Culture Identification Panel.使用FilmArray血培养鉴定板从阳性血培养物中快速鉴定念珠菌属菌种。
J Clin Microbiol. 2018 Nov 27;56(12). doi: 10.1128/JCM.01387-18. Print 2018 Dec.
4
5
Thinking beyond the Common Candida Species: Need for Species-Level Identification of Candida Due to the Emergence of Multidrug-Resistant Candida auris.超越常见念珠菌物种的思考：由于耐多药念珠菌耳念珠菌的出现，需要对念珠菌进行种水平鉴定。
J Clin Microbiol. 2017 Dec;55(12):3324-3327. doi: 10.1128/JCM.01355-17. Epub 2017 Sep 13.
6
Performance comparison of phenotypic and molecular methods for detection and differentiation of Candida albicans and Candida dubliniensis.表型和分子方法在检测和区分白念珠菌和杜氏念珠菌中的性能比较。
BMC Infect Dis. 2012 Sep 25;12:230. doi: 10.1186/1471-2334-12-230.
7
[Rapid identification of Candida dubliniensis using the Bichro-Dubli test].[使用双色 - 都柏林试验快速鉴定都柏林念珠菌]
Enferm Infecc Microbiol Clin. 2007 Nov;25(9):576-8. doi: 10.1157/13111184.
8
Methods of Candida dubliniensis identification and its occurrence in human clinical material.都柏林念珠菌的鉴定方法及其在人类临床样本中的出现情况。
Folia Microbiol (Praha). 2017 Sep;62(5):401-408. doi: 10.1007/s12223-017-0510-2. Epub 2017 May 17.
9
Hypertonic xylose agar medium: A novel medium for differentiation of from .高渗木糖琼脂培养基：一种用于从……中区分……的新型培养基。 （注：原文中“from”和“differentiation of”后面内容缺失，导致译文不太完整准确）
Indian J Med Microbiol. 2017 Oct-Dec;35(4):518-521. doi: 10.4103/ijmm.IJMM_17_216.
10
Identification of Candida dubliniensis in a diagnostic microbiology laboratory.诊断微生物学实验室中都柏林念珠菌的鉴定
East Mediterr Health J. 2005 May;11(3):366-71.
引用本文的文献
1
Molecular identification and antifungal susceptibility profiles of Candida dubliniensis and Candida africana isolated from vulvovaginal candidiasis: A single-centre experience in Iran.从伊朗单一中心经验看，从外阴阴道念珠菌病分离的杜伦毕赤酵母和南非假丝酵母的分子鉴定和抗真菌药敏谱。
Mycoses. 2021 Jul;64(7):771-779. doi: 10.1111/myc.13280. Epub 2021 May 3.
2
Recent Taxonomic Developments with and Other Opportunistic Yeasts.与念珠菌及其他机会性酵母相关的近期分类学进展。
Curr Fungal Infect Rep. 2012 Sep;6(3):170-177. doi: 10.1007/s12281-012-0094-x.
3
Candida dubliniensis encrustation of an obstructing upper renal tract calculus.上尿路梗阻性结石的都柏林念珠菌包壳形成
BMJ Case Rep. 2013 Aug 23;2013:bcr2013009087. doi: 10.1136/bcr-2013-009087.
本文引用的文献
1
Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods.氟康唑和念珠菌的野生型 MIC 分布、流行病学折点值和种特异性临床断点：CLSI 和 EUCAST 肉汤微量稀释方法协调的时机。
Drug Resist Updat. 2010 Dec;13(6):180-95. doi: 10.1016/j.drup.2010.09.002. Epub 2010 Nov 2.
2
National surveillance of fungemia in Denmark (2004 to 2009).丹麦的真菌血症全国监测（2004 年至 2009 年）。
J Clin Microbiol. 2011 Jan;49(1):325-34. doi: 10.1128/JCM.01811-10. Epub 2010 Oct 27.
3
Utility of a Luminex-based assay for multiplexed, rapid species identification of Candida isolates from an ongoing candidemia surveillance.基于 Luminex 技术的多重快速鉴定念珠菌分离株种属的方法在一项持续性念珠菌血症监测中的应用。
Can J Microbiol. 2010 Apr;56(4):348-51. doi: 10.1139/w10-003.
4
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion.ARTEMIS DISK 全球抗真菌监测研究结果，1997 年至 2007 年：10.5 年时间内通过 CLSI 标准化纸片扩散法测定的念珠菌属对氟康唑和伏立康唑的药敏性分析。
J Clin Microbiol. 2010 Apr;48(4):1366-77. doi: 10.1128/JCM.02117-09. Epub 2010 Feb 17.
5
Phenotypic methods and commercial systems for the discrimination between C. albicans and C. dubliniensis.用于区分白念珠菌和都柏林念珠菌的表型方法及商业系统。
Oral Dis. 2005 Nov;11(6):392-8. doi: 10.1111/j.1601-0825.2005.01135.x.
6
Azole susceptibility and resistance in Candida dubliniensis.都柏林念珠菌对唑类药物的敏感性和耐药性
Biochem Soc Trans. 2005 Nov;33(Pt 5):1210-4. doi: 10.1042/BST20051210.
7
Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans.都柏林念珠菌和白色念珠菌的流行病学、耐药机制及毒力比较
FEMS Yeast Res. 2004 Jan;4(4-5):369-76. doi: 10.1016/S1567-1356(03)00240-X.
8
Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.在接受氟康唑治疗的口咽念珠菌病的人类免疫缺陷病毒感染患者中，白色念珠菌被都柏林念珠菌取代。
J Clin Microbiol. 2002 Sep;40(9):3135-9. doi: 10.1128/JCM.40.9.3135-3139.2002.
9
Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro.来自人类免疫缺陷病毒（HIV）感染和未感染HIV受试者的口腔都柏林念珠菌分离株的抗真菌药敏性及体外稳定氟康唑耐药衍生物的产生
Antimicrob Agents Chemother. 1997 Mar;41(3):617-23. doi: 10.1128/AAC.41.3.617.
10
Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals.新型都柏林念珠菌：与HIV感染者口腔念珠菌病相关的新物种的表型和分子特征
Microbiology (Reading). 1995 Jul;141 ( Pt 7):1507-21. doi: 10.1099/13500872-141-7-1507.
Zotero 插件